Thursday, September 12th GCT Business Development team represented by Nataliya Katsnelson, BD Director and Elizaveta Medvedeva, BD Associate had a pleasure of participating in the NYC MedTech Forum. The presentations by the key speakers on the new NASH treatment method by Enzychem Lifesciences, Neuroimaging methods in detecting Alzheimer’s Disease by Frank A. Provenzano, and Hospital sequencing-based solutions by Biotia were mind-blowing. The forum was also a wonderful opportunity to connect with fellow professionals in the industry.

We are looking forward to the next year’s event!